2. Screening Libraries
  3. Anti-Orthopoxvirus Compound Library

Anti-Orthopoxvirus Compound Library

(37) Cat. No.: HY-L127
Library Contents: XLSX PDF

Orthopoxvirus is a genus of viruses in the family Poxviridae and subfamily Chordopoxvirinae. The orthopoxvirus genus consists of 12 viruses including variola virus, vaccinia virus (VV), cowpox viruses (CV), monkeypox virus, and camelpox virus. Smallpox has been eradicated worldwide in 1980, but some other orthopoxvirus, such as monkeypox virus, are still threats to human health.

There are not many drugs available for orthopoxvirus treatment. The only product currently available for treatment of complications of Orthopoxvirus infection is vaccinia immunoglobulin (VIG). In 2021, brincidofovir was approved by FDA for the treatment of smallpox and tecovirimat was approved by EMA for the treatment of monkeypox in 2022. A few active compounds including interferon and interferon inducers, and a variety of nucleosides or nucleotides have been reported to have activity against orthopoxvirus.

MCE carefully prepared a unique collection of 37 compounds reported with the anti- orthopoxvirus activity which can be used for drug screening and other research about orthopoxvirus.

Size (Pre-dissolved DMSO or Solid) Price Stock
30 μL/well (10 mM solution) Get quote In-stock
50 μL/well (10 mM solution) Get quote In-stock
100 μL/well (10 mM solution) Get quote In-stock
250 μL/well (10 mM solution) Get quote In-stock
Download Screening Library Catalog

Please contact us at

sales@MedChemExpress.com

Top Publications Citing Use of Products

Customer Validation

MCE Screening Library Partners

  • Description

  • Product Details

  • Composition

  • Contents

  • Documentation

Description
& Advantages

•   A unique collection of 37 bioactive compounds with anti-orthopoxvirus for high throughput screening (HTS) and high content screening (HCS).

•   Targets include variola virus, monkeypox, cowpox viruses, etc.

•   A useful tool for the research about orthopoxvirus.

•   Bioactivity and safety confirmed by preclinical research and clinical trials. Some have been approved by FDA.

•   Structurally diverse, medicinally active, and cell permeable.

•   Detailed compound information with structure, IC50, and brief introduction.

•   Validated NMR and HPLC to ensure high purity and quality.

•   All compounds are in stock and continuously updated.

Product Details
Formulation:
A collection of 37 bioactive anti-Orthopoxvirus compounds supplied as pre-dissolved Solutions or Solid.
Container:
96- or 384-well Plate with Peelable Foil Seal; 96-well Format Sample Storage Tube With Screw Cap and Optional 2D Barcode
Storage:
-80°C
Shipping:
Blue ice
Composition
Contents of Anti-Orthopoxvirus Compound Library
Documentation

Inquiry Online

Your information is safe with us. * Required Fields.

Product name

  

Salutation

Applicant name *

 

Email address *

Phone number

  

Organization name *

Country *

  

Requested quantity *

Remarks

Bulk Inquiry

Inquiry Information

Product Name:
Anti-Orthopoxvirus Compound Library
Cat. No.:
HY-L127
Quantity:

Request SDF File

Please enter your email address. We will send your requested SDF file to you as soon as possible.